🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015–2018

Clinical Infectious Diseases(2020)10.1093/cid/ciaa407Source: DataRank Database

Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015–2018 is a research paper published in Clinical Infectious Diseases (2020). On theSindex it has a DataRank of 0. It has been cited 60 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access60 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (18 grants)Impact (FWCI 5.48)OA: greenTopics (56)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Jessie R. Chung ORCID,Emily Smith ORCID,H. Keipp Talbot ORCID,Christopher Trabue,Richard K. Zimmerman ORCID

Live enrichment

PubMed:32270198 OpenAlex:https://openalex.org/W3015472143

Centers for Disease Control and Prevention

Grant: U01IP001034-U01IP001039

Centers for Disease Control and Prevention

Grant: IP15-002

Centers for Disease Control and Prevention

Grant: U01IP000969

Centers for Disease Control and Prevention

Grant: 5U01 IP000473-05

Core_RT-PCR based Case-Control: Apt Measure of Influenza Vaccine Effectiveness

Centers for Disease Control and Prevention

Grant: 5U01 IP001039-01-02

Centers for Disease Control and Prevention

Grant: 5U01IP000972-01-03

National Institutes of Health

Grant: UL1TR001857

National Institutes of Health

Grant: 5U01IP001034-03

US Influenza Vaccine Effectiveness Network

National Institutes of Health

Grant: 5U01IP000972-04

Core_Apt Measure of PCR-based Influenza Vaccine Effectiveness in Inpatient Adults

National Institutes of Health

Grant: 5U01IP001039-03

Mandatory_Estimates of Vaccine Effectiveness Against Medically-Attended, PCR-Confirmed Influenza in West South Central U.S.

National Institutes of Health

Grant: 3UL1TR001857-07S1

University of Pittsburgh Clinical and Translational Science Institute

National Institutes of Health

Grant: 5U01IP000969-03

Flu vaccine effectiveness in those hospitalized in a large diverse health system

NCIRD CDC HHS

Grant: U01 IP000473

ACL HHS

Grant: U01IP000972

NCIRD CDC HHS

Grant: U01 IP001039

NCIRD CDC HHS

Grant: U01 IP001034

NCIRD CDC HHS

Grant: U01 IP001035

NCIRD CDC HHS

Grant: U01 IP001038

FWCI

5.48

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: public-domain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8326549

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8326549

publisherhttp://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa407/33374214/ciaa407.pdf

publisherhttp://academic.oup.com/cid/article-pdf/73/3/386/39508580/ciaa407.pdf

journalhttps://doi.org/10.1093/cid/ciaa407

Fields of Study

Influenza Virus Research StudiesRespiratory viral infections researchCOVID-19 epidemiological studies03 medical and health sciences0302 clinical medicineAdultHumansInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza VaccinesInfluenza, HumanInpatientsOutpatientsSeasonsUnited StatesVaccination

MeSH Terms

AdultHumansInfluenza, HumanInfluenza VaccinesInpatientsOutpatientsSeasonsUnited StatesVaccinationInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 Subtype

Keywords

MedicineConfidence intervalVaccinationInfluenza vaccineLogistic regressionInfluenza-like illnessOdds ratioInternal medicineOutpatient clinicRespiratory illnessPediatricsImmunologyRespiratory systemVirusAdultInpatientsInfluenza A Virus, H3N2 SubtypeUnited StatesInfluenza A Virus, H1N1 SubtypeInfluenza VaccinesInfluenza, HumanOutpatientsHumansSeasonsattenuationhospitalizationinfluenzaseverityvaccine effectiveness

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Related Papers (5)

Waning Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2015–2016 to 2018–2019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network

Clinical Infectious Diseases(2021)

co-citedsame journal

10.1093/cid/ciab045

Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial

N/A

0.845DataRank · unranked

The Lancet HIV(2020)

co-cited

10.1016/s2352-3018(19)30322-4

Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis

N/A

0.688DataRank · unranked

The Lancet Respiratory Medicine(2022)

co-cited

10.1016/s2213-2600(22)00266-1

Message in a bottle: mRNA vaccination for influenza

Journal of General Virology(2022)

co-cited

10.1099/jgv.0.001765

How repeated influenza vaccination effects might apply to COVID-19 vaccines

The Lancet Respiratory Medicine(2022)

co-cited

10.1016/s2213-2600(22)00162-x